bay-k-8644 and amiloride

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Calcium Channel Blockers; Calcium Channels; Cell Membrane Permeability; Cells, Cultured; Dihydropyridines; Electrophysiology; Hippocampus; Kinetics; Neurons; Nickel; omega-Conotoxin GVIA; Peptides, Cyclic; Rats

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Calcium; Calcium Channels; Cell Separation; Egtazic Acid; Electrophysiology; Homeostasis; Osmolar Concentration; Portal Vein; Rabbits; Reaction Time

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Arteries; Calcium; Calcium Radioisotopes; Female; Humans; In Vitro Techniques; Isometric Contraction; Monensin; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Ouabain; Placenta; Regional Blood Flow; Sodium; Veins

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Differentiation; Cell Membrane Permeability; Dihydropyridines; Electric Conductivity; Humans; Kinetics; Mollusk Venoms; Neuroblastoma; Neurons; Nickel; omega-Conotoxin GVIA; Tumor Cells, Cultured

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Amiloride; Animals; Biological Transport, Active; Heart Atria; Myocardial Contraction; Ouabain; Phenylephrine; Potassium Channels; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Sodium; Sodium Channels

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acidosis; Amiloride; Animals; Calcium; Guinea Pigs; Heart; Hydrogen; Hydrogen-Ion Concentration; In Vitro Techniques; Ion Exchange; Myocardial Contraction; Myocardium; Ouabain; Sodium

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alprostadil; Amiloride; Amino Acid Sequence; Analgesics; Animals; Benzeneacetamides; Chlorides; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Gluconates; Guinea Pigs; Intestinal Mucosa; Male; Membrane Potentials; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin; Tetrodotoxin; Theophylline

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Arginine Vasopressin; Biological Transport; Cells, Cultured; Electrophysiology; Hydrogen-Ion Concentration; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Potassium; Rats; Rats, Inbred WKY; Sodium; Vascular Resistance

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Binding Sites; Biological Transport, Active; Calcium; Dinoprost; Humans; Monensin; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Ouabain; Placenta; Potassium; Rubidium; Sodium-Potassium-Exchanging ATPase; Veins

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Heart Ventricles; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Ouabain; Rats; Rats, Inbred Strains

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Calcium; Electric Stimulation; Guinea Pigs; Heart; In Vitro Techniques; Ion Exchange; Myocardial Contraction; Rats; Sodium; Species Specificity

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Cells, Cultured; Cholinergic Fibers; Conotoxins; Ions; Kinetics; Membrane Potentials; Nickel; Nifedipine; Peptides, Cyclic; Prosencephalon; Rats; Rats, Sprague-Dawley

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Adenosine Triphosphate; Amiloride; Animals; Barium; Calcium; Calcium Channels; Cell Line; Epithelial Cells; Epithelium; Intracellular Membranes; Isradipine; Membrane Potentials; Patch-Clamp Techniques; Pulmonary Alveoli; Rats; Receptors, Purinergic; Sodium; Strontium

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Amiloride; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cyclic AMP; Mice; Nickel; Nifedipine; Spectrometry, Fluorescence; Steroids; Tumor Cells, Cultured

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Calcium Channel Agonists; Female; Goldfish; Gonadotropin-Releasing Hormone; Growth Hormone; Ionomycin; Male; Pituitary Gland; Sodium; Sodium Channels; Sodium-Hydrogen Exchangers; Tetradecanoylphorbol Acetate; Tetrodotoxin

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Analysis of Variance; Animals; Calcium Channel Blockers; Calcium Channels; Dogs; Dose-Response Relationship, Drug; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nifedipine; Perfusion; Random Allocation; Sodium-Calcium Exchanger; Time Factors

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Barium; Benzimidazoles; Blotting, Northern; Cadmium; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Channels, T-Type; Cells, Cultured; Cloning, Molecular; Diuretics; DNA, Complementary; Electric Stimulation; Electrophysiology; Humans; Ion Channel Gating; Kidney; Kinetics; Membrane Potentials; Mibefradil; Molecular Sequence Data; Nickel; Nimodipine; Oocytes; Recombinant Proteins; RNA, Messenger; Sequence Homology, Amino Acid; Tetrahydronaphthalenes; Transcription, Genetic; Verapamil; Xenopus

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Medulla; Amiloride; Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Channels, T-Type; Cattle; Dihydropyridines; Electric Conductivity; Electrophysiology; Endothelium; Ion Channel Gating

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Amiloride; Angiotensin II; Animals; Antihypertensive Agents; Benzofurans; Biphenyl Compounds; Calcium; Calcium Channel Agonists; Cell Line; Cells, Cultured; Chelating Agents; Cytosol; Dogs; Dose-Response Relationship, Drug; Egtazic Acid; Ethers, Cyclic; Fluorescent Dyes; Fura-2; Imidazoles; Imipramine; Irbesartan; Kidney; Kinetics; Magnesium; Microscopy, Fluorescence; Peptides; Pyridines; Quinidine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium; Tetrazoles; Time Factors

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Aorta, Thoracic; Autonomic Denervation; Blood Pressure; Boron Compounds; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Chloride Channels; Dose-Response Relationship, Drug; Inositol 1,4,5-Trisphosphate Receptors; Male; Membrane Transport Modulators; Nitrobenzoates; Periodicity; Phenylephrine; Rats; Rats, Wistar; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium Channel Blockers; Sodium-Calcium Exchanger; Thapsigargin; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Verapamil

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amiloride; Animals; Astrocytes; Biophysics; Calcium; Calcium Channel Blockers; Cell Death; Cells, Cultured; Cysteine Proteinase Inhibitors; Cytosol; Dose-Response Relationship, Drug; Electric Stimulation; Embryo, Mammalian; Endoplasmic Reticulum; Excitatory Amino Acid Agonists; Lactones; Leupeptins; Membrane Potentials; Mice; Neocortex; Neurons; Patch-Clamp Techniques; Proteasome Inhibitors; Sesquiterpenes; Time Factors

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Animals; Barium; Bone Marrow Cells; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Cell Proliferation; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Sodium Channels; Kinetics; Membrane Potentials; Mice; Nifedipine; ortho-Aminobenzoates; Patch-Clamp Techniques; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium; Sodium Channel Blockers; Stromal Cells